Thomas Davie
Bluelight Crew
You're probably right neurotic. This idea of 1P-LSD being active in its own right, and more readily able to cross the BBB, could easily be fanciful thinking.
Perhaps. But there is something that users can do to help determine this (it does depend on fastidious note taking though).
You know the tolerance curve for mushrooms/LSD that people have contributed to that is viewable on this site? Well, if people are willing to put that much effort into 1p-LSD, it might be possible to get a better idea of whether or not the drug can cross the BBB.
1) note whether you take the drug buccal/sublingual (say 15 minutes and then spit out or swallow) or oral (straight down the hatch, no leaving it around in the mouth at all). Having previously written down what you have eaten in the last 12 hours (I figure that's enough time to account for stomach emptying and note whether or not you've had a bowel movement in this time period.
2) write down how quickly first alerts/effects are felt
3) write down, if possible, how strong (out of 10) you feel the trip is.
Only data point 3 is subjective; the other 2 are objective facts. If there is a difference in how the drugs hits buccal/sublingual .vs. oral then you have some kind of answer to this question.
As an example thought idea, even if you take the drug orally, absorption might be delayed sufficiently that, even though the BBB could be crossed you won't notice speed of onset (or perhaps strength of effect). Buccal/sublingual should see both affected if true BBB passage is seen.
Tom